TMCI•globenewswire•
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue
Summary
PONTE VEDRA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced its preliminary, unaudited fourth quarter and full-year 2025 revenue results.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 13, 2026 by globenewswire